Corrigendum: Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders. [PDF]
Front Mol Neurosci, 2018 [This corrects the article DOI: 10.3389/fnmol.2018.00387.].
Fisher NM +3 more
europepmc +8 more sources
Can Metabotropic Glutamate Receptor 7 (mGluR 7) be a Novel Target for Analgesia? [PDF]
J Clin Diagn Res, 2014 INTRODUCTION The present study was carried out to study the role of metabotropic glutamate receptor 7 (mGluR7) using its agonist, N,N'-bis(diphenylmethyl)-1,-ethanediamine (AMN082) for nociceptive stimuli, in animal models.
G S +6 more
europepmc +7 more sources
Activating metabotropic glutamate receptor‑7 attenuates visceral hypersensitivity in neonatal maternally separated rats. [PDF]
Int J Mol Med, 2019 Increasing evidence has indicated that metabotropic glutamate receptor-7 (mGluR7) is an important target for reducing anxiety and stress-associated behaviours.
Shao L +5 more
europepmc +7 more sources
Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders. [PDF]
Front Mol Neurosci, 2018 Neurodevelopmental disorders (NDDs) are characterized by a wide range of symptoms including delayed speech, intellectual disability, motor dysfunction, social deficits, breathing problems, structural abnormalities, and epilepsy.
Fisher NM +3 more
europepmc +7 more sources
Constitutive activity of metabotropic glutamate receptor 7. [PDF]
BMC Neurosci, 2015 Metabotropic glutamate receptors (mGluRs) are class C G protein coupled receptors with widespread central nervous system expression. mGluR7 is a member of this family that has been implicated in numerous physiological and pathological processes, but the very low potency of mGluR7 for glutamate, its natural ligand, raise questions about the nature of ...
Kammermeier PJ.
europepmc +7 more sources
Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications. [PDF]
Curr Neuropharmacol, 2016 Metabotropic glutamate receptor 7 (mGluR7) is localized presynaptically at the active zone of neurotransmitter release. Unlike mGluR4 and mGluR8, which share mGluR7’s presynaptic location, mGluR7 shows low affinity for glutamate and is activated only by ...
Palazzo E +4 more
europepmc +7 more sources
Regulation of N-methyl-D-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7. [PDF]
J Biol Chem, 2012 Background: The metabotropic glutamate receptors (mGluRs) are potential novel targets for mental disorders. Results: Activation of mGluR7 significantly reduced NMDAR-mediated currents and NMDAR surface expression via an actin-dependent mechanism ...
Gu Z, Liu W, Wei J, Yan Z.
europepmc +7 more sources
G-alpha interacting protein interacting protein, C terminus 1 regulates epileptogenesis by increasing the expression of metabotropic glutamate receptor 7. [PDF]
CNS Neurosci Ther, 2022 It has been reported that the G‐alpha interacting protein (GAIP) interacting protein, C terminus 1 (GIPC1/GIPC) engages in vesicular trafficking, receptor transport and expression, and endocytosis. However, its role in epilepsy is unclear.
Liu Y +7 more
europepmc +4 more sources
Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus. [PDF]
J Neurosci, 2015 Of the eight metabotropic glutamate (mGlu) receptor subtypes, only mGlu7 is expressed presynaptically at the Schaffer collateral (SC)-CA1 synapse in the hippocampus in adult animals. Coupled with the inhibitory effects of Group III mGlu receptor agonists
Klar R +9 more
europepmc +4 more sources
Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant Dependence. [PDF]
CNS Neurol Disord Drug Targets, 2015 Although few medications have been approved by the U.S. Food and Drug Administration (FDA) to assist people to quit tobacco smoking, there are no FDA-approved medications to treat dependence on other psychostimulant drugs, such as cocaine. The motivation
Li X, Markou A.
europepmc +6 more sources